CTHRC1 and chronic thromboembolic pulmonary hypertension: Elevated plasma levels of CTHRC1 correlate with clinical indicators of right ventricular failure, and its levels decrease following successful balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH), suggesting its role in monitoring therapeutic efficacy [68, 69].